Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Paratek Pharmaceuticals I...

    NASDAQ: PRTK · Real-Time Price · USD
    2.23
    0.04 (1.83%)
    At close: Sep 20, 2023, 10:00 PM

    Paratek Pharmaceuticals Statistics

    Share Statistics

    Paratek Pharmaceuticals has 57.32M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 57.32M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 50.11M

    Failed to Deliver (FTD) Shares

    n/a
    		 110,528

    FTD / Avg. Volume

    n/a
    		 18.43%

    Short Selling Information

    The latest short interest is 2.75M, so 4.81% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.75M

    Short % of Shares Out

    n/a
    		 4.81%

    Short % of Float

    n/a
    		 5.83%

    Short Ratio (days to cover)

    n/a
    		 6.27

    Valuation Ratios

    The PE ratio is -1.6 and the forward PE ratio is null. Paratek Pharmaceuticals's PEG ratio is 0.39.

    PE Ratio

    n/a
    		 -1.6

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0.67

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -0.59

    P/FCF Ratio

    n/a
    		 -1.54

    PEG Ratio

    n/a
    		 0.39
    Financial Ratio History

    Enterprise Valuation

    Paratek Pharmaceuticals has an Enterprise Value (EV) of 325.87M.

    EV / Sales

    n/a
    		 2.16

    EV / EBITDA

    n/a
    		 -7.26

    EV / EBIT

    n/a
    		 -4.93

    EV / FCF

    n/a
    		 -4.92

    Financial Position

    The company has a current ratio of 3.66, with a Debt / Equity ratio of -1.51.

    Current Ratio

    n/a
    		 3.66

    Quick Ratio

    n/a
    		 3.22

    Debt / Equity

    n/a
    		 -1.51

    Debt / EBITDA

    n/a
    		 -5.76

    Debt / FCF

    n/a
    		 -3.9

    Interest Coverage

    n/a
    		 -2.55

    Financial Efficiency

    Return on Equity is 37.16% and Return on Invested Capital is -52.94%.

    Return on Equity

    n/a
    		 37.16%

    Return on Assets

    n/a
    		 -36.84%

    Return on Invested Capital

    n/a
    		 -52.94%

    Revenue Per Employee

    n/a
    		 $562,641.79

    Profits Per Employee

    n/a
    		 $-237,186.57

    Employee Count

    n/a
    		 268

    Asset Turnover

    n/a
    		 0.87

    Inventory Turnover

    n/a
    		 1.39

    Taxes

    Income Tax

    n/a
    		 57K

    Effective Tax Rate

    n/a
    		 -0.09%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 1.7, so Paratek Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.7

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 2.2

    200-Day Moving Average

    n/a
    		 2.07

    Relative Strength Index (RSI)

    n/a
    		 59.19

    Average Volume (20 Days)

    n/a
    		 599,679

    Income Statement

    In the last 12 months, Paratek Pharmaceuticals had revenue of 150.79M and earned -63.57M in profits. Earnings per share was -1.17.

    Revenue

    n/a
    		 150.79M

    Gross Profit

    n/a
    		 127.73M

    Operating Income

    n/a
    		 -46.21M

    Net Income

    n/a
    		 -63.57M

    EBITDA

    n/a
    		 -44.9M

    EBIT

    n/a
    		 -45.39M

    Earnings Per Share (EPS)

    n/a
    		 -1.17
    Full Income Statement

    Balance Sheet

    The company has 34.25M in cash and 258.41M in debt, giving a net cash position of -224.17M.

    Cash & Cash Equivalents

    n/a
    		 34.25M

    Total Debt

    n/a
    		 258.41M

    Net Cash

    n/a
    		 -224.17M

    Retained Earnings

    n/a
    		 -930.45M

    Total Assets

    n/a
    		 145.79M

    Working Capital

    n/a
    		 -97.39M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -66.14M and capital expenditures -36K, giving a free cash flow of -66.18M.

    Operating Cash Flow

    n/a
    		 -66.14M

    Capital Expenditures

    n/a
    		 -36K

    Free Cash Flow

    n/a
    		 -66.18M

    FCF Per Share

    n/a
    		 -1.22
    Full Cash Flow Statement

    Margins

    Gross margin is 84.71%, with operating and profit margins of -30.65% and -42.16%.

    Gross Margin

    n/a
    		 84.71%

    Operating Margin

    n/a
    		 -30.65%

    Pretax Margin

    n/a
    		 -42.12%

    Profit Margin

    n/a
    		 -42.16%

    EBITDA Margin

    n/a
    		 -29.78%

    EBIT Margin

    n/a
    		 -30.65%

    FCF Margin

    n/a
    		 -43.89%

    Dividends & Yields

    PRTK does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -62.5%

    FCF Yield

    n/a
    		 -65.07%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for PRTK.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 31, 2014. It was a backward split with a ratio of 1:12.

    Last Split Date

    n/a
    		 Oct 31, 2014

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:12

    Scores

    Altman Z-Score

    n/a
    		 -9.7

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist